Delisted

No longer trades. Fund positions are valued at its last close, $17.03 on Sep 23, 2026. View SEC filing

TBPH

THERAVANCE BIOPHARMA INC

TBPH (THERAVANCE BIOPHARMA INC) is held by 1 institutional investors as of Q3 2026. Top institutional shareholders: Glenmede Trust Co. N.A. ($9,329).

No verdict yet — fewer than 2 funds hold TBPH.

Top Holders

Fund ownership
Fund holdings as of
Funds holding1
avg
Value of reported holdings$9,329
Funds buying / selling
Not available
Checking access…
Action
New
639$9,3290.0%—
26
Exited
0(-100.0%)$659,6000.0%—
0
Exited
0(-100.0%)$1M0.0%—
0
Exited
0(-100.0%)$196,6900.0%—
0
Exited
0(-100.0%)$435,4040.0%—
0
Exited
0(-100.0%)$187,1530.0%—
0
Exited
0(-100.0%)$448,1030.0%—
0
Exited
0(-100.0%)$1.3M0.0%—
0
Exited
0(-100.0%)$22.6M0.0%—
0
Exited
0(-100.0%)$209,2700.0%—
0
Exited
0(-100.0%)$977,9080.0%—
0
Exited
0(-100.0%)$1.1M0.0%—
0
Exited
0(-100.0%)$690,4210.0%—
0
Exited
0(-100.0%)$591,1070.0%—
0
Exited
0(-100.0%)$1.3M0.0%—
0
Exited
0(-100.0%)$316,9140.0%—
0
Exited
0(-100.0%)$27,7440.0%—
0
Exited
0(-100.0%)$271,8470.0%—
0
Exited
0(-100.0%)$300,5770.0%—
0
Exited
0(-100.0%)$842,7470.0%—
0

Showing 1-20 of 113

1 / 6
Latest insider trades
InsiderTradeTraded
Winningham Rick EDisp
Miller AineDisp
Sawaf AzizDisp
Grimaud Brett A.Disp
Grimaud Brett A.Disp
Winningham Rick EDisp
Weiss Asset Management LPOther 7.5M sh
Samaha EliOther 9.2M sh
Sawaf AzizDisp
Farnum RhondaDisp
Loading Congress trades…
Latest activist filings
FilerStakeFiled
Newtyn Management, LLC0.0%
Madison Avenue International LP0.0%
Weiss Asset Management LP0.0%
Newtyn Management, LLC6.7%
Madison Avenue International LP17.7%
Weiss Asset Management LP14.5%
Newtyn Management, LLC8.5%
BlackRock, Inc.6.5%
TBPHTBPHTHERAVANCE BIOPHARMA INC

Other Healthcare stocks held by institutions

Questions investors ask about TBPH

Who owns TBPH?

1 institutional investor held TBPH on September 30, 2026, led by Glenmede Trust Co. N.A. ($9,329).

How many hedge funds hold TBPH?

1 institutional investor reported TBPH in their 13F filings for the quarter ended September 30, 2026, $9,329 in all.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Optional analytics helps us improve. How it’s used